Eyenovia Inc. (EYEN)
1.19
0.06 (5.31%)
At close: Apr 02, 2025, 3:57 PM
1.16
-2.77%
After-hours: Apr 02, 2025, 07:00 PM EDT
5.31% (1D)
| Bid | 1.03 |
| Market Cap | 2.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -55.2 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -0.12 |
| Analyst | Hold |
| Ask | 1.24 |
| Volume | 39,588 |
| Avg. Volume (20D) | 359,119 |
| Open | 1.14 |
| Previous Close | 1.13 |
| Day's Range | 1.11 - 1.19 |
| 52-Week Range | 1.06 - 124.80 |
| Beta | 1.29 |
About EYEN
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impair...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 25, 2018
Employees 57
Stock Exchange NASDAQ
Ticker Symbol EYEN
Website https://www.eyenovia.com
Analyst Forecast
According to 4 analyst ratings, the average rating for EYEN stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 68.10% from the latest price.
Stock ForecastsNext Earnings Release
Eyenovia Inc. is scheduled to release its earnings on Apr 15, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-13.77%
Eyenovia shares are trading lower after the compan...
Unlock content with
Pro Subscription
1 month ago
+16.56%
Eyenovia shares are trading higher after the company announced it regained Nasdaq complaince.
